Pharmaceutical giant Pfizer has signed a 310MW virtual power purchase agreement (VPPA) with Texan renewable energy company Vesper Energy under a 15-year agreement.
The agreement will see Vesper deliver at least 310MW of renewable energy to the grid that will “effectively power 100% of the projected power needs of Pfizer’s North American operations through clean solar energy,” said Vesper Energy.
Unlock unlimited access for 12 whole months of distinctive global analysis
Photovoltaics International is now included.
- Regular insight and analysis of the industry’s biggest developments
- In-depth interviews with the industry’s leading figures
- Unlimited digital access to the PV Tech Power journal catalogue
- Unlimited digital access to the Photovoltaics International journal catalogue
- Access to more than 1,000 technical papers
- Discounts on Solar Media’s portfolio of events, in-person and virtual
Or continue reading this article for free
The solar energy will be generated from Vesper’s 500MW Hornet Solar project in west Texas, which will be fully operational by the end of 2023.
“Vesper’s Hornet Solar project is a strong example of how we put high-quality renewable infrastructure to work to solve our customers’ energy challenges, while making meaningful contributions to the greater sustainability movement,” said Vesper CEO Craig Carson.
At the end of last year, Vesper closed a letter of credit facility for up to US$100 million and stated its intention to accelerate the development of its solar and storage pipeline in North America.
